Nadège Corradini Selected Research

Paraffin

1/2022

Wholistic approach: Transcriptomic analysis and beyond using archival material for molecular diagnosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nadège Corradini Research Topics

Disease

36	Neoplasms (Cancer) 04/2024 - 09/2009
14	Sarcoma (Soft Tissue Sarcoma) 10/2022 - 11/2009
11	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 11/2009
10	Rhabdomyosarcoma 12/2023 - 11/2009
7	Neoplasm Metastasis (Metastasis) 11/2023 - 10/2010
7	Ewing Sarcoma (Sarcoma, Ewing) 01/2023 - 11/2009
4	Neuroblastoma 02/2024 - 11/2016
2	Aggressive Fibromatosis (Desmoid) 10/2023 - 01/2021
2	Fibroma (Fibromatosis) 10/2023 - 01/2021
2	Brain Neoplasms (Brain Tumor) 01/2023 - 07/2012
2	Central Nervous System Neoplasms 10/2022 - 01/2020
2	Disease Progression 01/2021 - 01/2020
2	Medulloblastoma 01/2020 - 01/2018
2	Dysgerminoma 01/2018 - 02/2011
2	Bone Resorption 01/2016 - 10/2011
1	Fibrosarcoma 01/2024
1	Mesoblastic Nephroma (Congenital Mesoblastic Nephroma) 01/2024
1	Pain (Aches) 10/2023
1	Infections 07/2023
1	Genetic Translocation (Chromosomal Translocation) 01/2023
1	Drug-Related Side Effects and Adverse Reactions 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022
1	Hypoxia (Hypoxemia) 10/2020
1	Paraganglioma (Paragangliomas) 05/2020
1	Malignant mesenchymal tumor 01/2020
1	Giant Cell Tumors (Giant Cell Tumor) 01/2020
1	Hodgkin Disease (Hodgkin's Disease) 01/2020
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020
1	Second Primary Neoplasms (Neoplasms, Second) 01/2020
1	Primitive Neuroectodermal Tumors (PNET) 01/2020
1	Ototoxicity 07/2018
1	Mesothelioma 04/2018
1	Glioma (Gliomas) 01/2018
1	Ependymoma 01/2018
1	Cardiomyopathies (Cardiomyopathy) 08/2016

Drug/Important Bio-Agent (IBA)

7	RNA (Ribonucleic Acid)IBA 04/2024 - 07/2015
4	Topotecan (Hycamtin)FDA LinkGeneric 11/2023 - 10/2010
4	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 03/2011
4	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 01/2018
4	Zoledronic Acid (Zometa)FDA Link 08/2016 - 10/2010
3	Irinotecan (Camptosar)FDA LinkGeneric 11/2023 - 07/2012
3	Vinorelbine (Navelbine)FDA LinkGeneric 10/2023 - 10/2012
3	Tyrosine Kinase InhibitorsIBA 10/2022 - 01/2020
3	Ifosfamide FDA LinkGeneric 01/2022 - 01/2018
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 10/2012
3	Temozolomide (Temodar)FDA LinkGeneric 11/2021 - 10/2010
3	Sirolimus (Rapamycin)FDA Link 11/2021 - 11/2015
2	Phosphotransferases (Kinase)IBA 01/2024 - 07/2023
2	Vincristine (Oncovin)FDA LinkGeneric 11/2023 - 01/2022
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2020
2	NucleotidesIBA 01/2022 - 01/2018
2	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2020 - 12/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 07/2018
2	PlatinumIBA 07/2018 - 01/2018
2	Carboplatin (JM8)FDA LinkGeneric 07/2018 - 03/2011
2	Cell-Free Nucleic AcidsIBA 01/2018 - 11/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2017 - 07/2012
2	Diphosphonates (Bisphosphonates)IBA 10/2011 - 10/2010
1	tyrosine receptor (receptor, tyrosine)IBA 01/2024
1	Drug CombinationsIBA 12/2023
1	regorafenibIBA 11/2023
1	3-Iodobenzylguanidine (Iobenguane)IBA 11/2023
1	Pattern Recognition ReceptorsIBA 07/2023
1	Toll-Like Receptor 3IBA 07/2023
1	TropomyosinIBA 07/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	entrectinibIBA 10/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	ParaffinIBA 01/2022
1	vistusertibIBA 11/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2021
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2021
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 05/2020
1	atezolizumabIBA 01/2020
1	CI 22IBA 01/2020
1	AntibodiesIBA 01/2020
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	penicillamine-glutathione mixed disulfideIBA 01/2019
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018
1	MB 5IBA 01/2018
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 06/2017
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 06/2017
1	DNA (Deoxyribonucleic Acid)IBA 11/2016
1	Ethanolamine (Colamine)IBA 01/2016
1	mifamurtideIBA 01/2016
1	EWS-FLI fusion proteinIBA 07/2015

Therapy/Procedure

17	Drug Therapy (Chemotherapy) 08/2022 - 08/2010
16	Therapeutics 02/2024 - 08/2010
5	Radiotherapy 08/2021 - 06/2013
4	Investigational Therapies (Experimental Therapy) 02/2024 - 02/2012
2	Induction Chemotherapy 11/2023 - 01/2021
2	Aftercare (After-Treatment) 07/2017 - 11/2009
1	Duration of Therapy 10/2022
1	Autologous Transplantation 01/2020
1	Cytoreduction Surgical Procedures 04/2018
1	Hyperthermic Intraperitoneal Chemotherapy 04/2018
1	Intravenous Infusions 08/2016
1	Off-Label Use 11/2015